Search for: "TEVA PHARMACEUTICAL INDUSTRIES LTD" Results 141 - 160 of 259
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Nov 2020, 6:31 am by Deb Givens
  The European Commission has fined pharmaceutical company Teva and its now subsidiary Cephalon 60.5 million euros for agreeing to delay a cheaper generic version of Cephalon’s sleep disorder medicine. [read post]
30 Apr 2021, 8:07 am by Dan Bressler
The department has taken issue with the firm’s prior representation of fellow defendant Teva Pharmaceutical Industries Ltd. in the criminal probe and its continued representation of both companies in parallel civil litigation. [read post]
2 Dec 2009, 4:31 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page:   Highlights this week included: World AIDS Day: Make it happen (Patent Baristas) (IP Watch) Venezuela to examine all pharmaceutical patents (IP tango)   General World AIDS Day: Make it happen (Patent Baristas) (IP Watch) Biodiversity negotiations need to allow for flexibility in business, industry says (IP Watch) Brazilian government tailors… [read post]
24 Mar 2012, 1:20 pm by Stewart Walsh
CAFC Rules “Secret Prior Art” Requires Only Appreciation that Invention Made in Teva Pharmaceutical*The doctrines of “secret prior art” and “inherency” both merged in the case Teva Pharmaceutical Industries Ltd. v. [read post]
19 Aug 2008, 11:07 am
``It didn't take an extraordinarily long amount of conversation before he said, `Yeah, I want to do something on this,''' said Barrett, now vice president of government affairs in Washington for generic-drug maker Teva Pharmaceutical Industries Ltd. of Petah Tikva, Israel.A narrower version of the measure, allowing quicker access to generics in certain circumstances, eventually passed. [read post]
21 Jan 2007, 8:53 pm
N.J.), and Teva Pharmaceutical Industries, Ltd., No. 04-CV-886-HAA-GDH (D. [read post]
13 Jul 2021, 6:11 am by Annsley Merelle Ward
Teva Pharmaceutical Industries Ltd and Teva Pharma Belgium NVTeva is the exclusive licensee of EP 2 949 335 (“EP’335”), a European patent relating to a low frequency glatiramer acetate therapy owned by Yeda Research and Development Co. [read post]
3 Nov 2010, 7:00 am
Teva Pharmaceutical Industries Ltd. followed the same year. [read post]
18 Oct 2007, 11:00 pm
Quite right, said the CFI, dismissing Intervideo's appeal - CFI decision in Case T-105/06 Intervideo v OHIM, (IPKat)EPO adds EPC post-grant data to PRS database (EPO), EU Patent Jurisdiction: Details of New Proposals From Portuguese EU Presidency (Blog@IPR::JUR), (IAM), Teva invalidates acid metabolite patents for terfenedine, (Teva Pharmaceutical Industries Ltd and another v Merrell Pharmaceuticals Inc, Aventis and Sepracor [2007] EWHC… [read post]
10 Oct 2008, 11:32 am
:Interpharma Pty Ltd v Commisioner of Patents (GenericsWeb) Gemzar (Gemcitabine) - US: Eli Lilly sues Teva for patent infringement and seek declaratory judgment (The IP Factor) (Law360) Glivec (Imatinib) - India: Supreme Court appoints Dr Chakraborty as technical member on IPAB panel hearing Glivec appeal (Spicy IP) Jeevani (Arogyapacha) - India: Recent developments in the Arogypacha case (Spicy IP) Miralax (Polyethylene glycol) - US: 'Advice of scientist'… [read post]
20 May 2010, 8:31 am
But again today, May 20, 2010 the firm has upgraded the stock from Hold to Buy.According to Benzinga’s Monica Gerson who writes that Standpoint analyst Ronnie Moas had also upgraded shares of Teva Pharmaceutical Industries Ltd (NASDAQ: TEVA), Dell Inc (NASDAQ: DELL), HP (NYSE: HPQ) and Xerox Corporation (NYSE: XRX), simultaneously, from “hold” to “buy. [read post]